Online Only Articles

Efficient CRISPR-Cas9 mediated gene disruption in primary erythroid progenitor cells

Whitehead Institute for Biomedical Research, Cambridge, MA, USA;Department of Pediatrics, Harvard Medical School, Boston, MA, USA;Division of Hematology and Oncology, Boston Children’s Hospital, Boston, MA, USA;Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Whitehead Institute for Biomedical Research, Cambridge, MA, USA
Whitehead Institute for Biomedical Research, Cambridge, MA, USA
Whitehead Institute for Biomedical Research, Cambridge, MA, USA;Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
Whitehead Institute for Biomedical Research, Cambridge, MA, USA
Whitehead Institute for Biomedical Research, Cambridge, MA, USA
Whitehead Institute for Biomedical Research, Cambridge, MA, USA;Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
Vol. 101 No. 6 (2016): June, 2016 https://doi.org/10.3324/haematol.2015.135723